Class II

Drug Recall: fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells pharma, NDC 73702-202-15.

Wells Pharma of Houston LLC · April 1, 2026

Reason for Recall

cGMP deviations.

Distribution

U.S. Nationwide.

States Affected

NATIONWIDE

Quantity Affected

50 syringes

Source: FDA (openFDA Drug Enforcement)

Recall number: D-0508-2026

Status: ongoing

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.

Wells Pharma of Houston LLC Drug Recall: fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells pharma, NDC 73702-202-15. | SafeCheck